These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35902329)

  • 1. Factors Associated With COVID-19 Breakthrough Infections: Correspondence.
    Mungmunpuntipantip R; Wiwanitkit V
    J Occup Environ Med; 2022 Nov; 64(11):e793. PubMed ID: 35902329
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: Factors Associated With COVID-19 Breakthrough Infections: Correspondence.
    Rivelli A; Fitzpatrick V; Copeland K; Richards J
    J Occup Environ Med; 2022 Nov; 64(11):e794. PubMed ID: 35902338
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of breakthrough infections after COVID-19 vaccination among the COVID-19 vaccine recipients at a Tertiary Care Hospital in Srinagar.
    Fazili A; Ain SN; Shah RJ; Raja FN; Farhat D; Nazir I
    Indian J Public Health; 2023; 67(2):305-308. PubMed ID: 37459029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakthrough SARS-CoV-2 infections after COVID-19 immunization.
    Hirsh J; Htay T; Bhalla S; Nguyen V; Cervantes J
    J Investig Med; 2022 Aug; 70(6):1429-1432. PubMed ID: 35768140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and Correlates of Breakthrough Infections With SARS-CoV-2.
    Yamal JM; Appana S; Wang M; Leon-Novelo L; Bakota E; Ye Y; Sharma S; Morrison AC; Marko D; Linder SH; Rector A; Jetelina KK; Boerwinkle E; de Oliveira Otto M
    Front Public Health; 2022; 10():856532. PubMed ID: 35619825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection.
    Heinzl MW; Kolenchery L; Resl M; Klammer C; Black A; Obendorf F; Schinagl L; Feldbauer R; Pohlhammer J; Wagner T; Berger T; Dieplinger B; Clodi M
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections.
    di Lego V; Sánchez-Romero M; Prskawetz A
    Int J Infect Dis; 2022 Jun; 119():178-183. PubMed ID: 35398301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases.
    Benny L; Mehta P; Ahmed S; Paul A; Sukumaran A; Mohanan M; Vijayan A; Kaveri K; Padmaja R; Shenoy P
    Rheumatol Int; 2023 Jun; 43(6):1033-1039. PubMed ID: 37029793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.
    Maltezou HC; Gamaletsou MN; Giannouchos TV; Koukou DM; Karapanou A; Sourri F; Syrimi N; Lemonakis N; Peskelidou E; Papanastasiou K; Souliotis K; Lourida A; Panagopoulos P; Hatzigeorgiou D; Sipsas NV
    J Hosp Infect; 2023 Feb; 132():46-51. PubMed ID: 36473554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With COVID-19 Breakthrough Infections in Large Midwestern Healthcare System: Implications for Vulnerable Healthcare Personnel.
    Rivelli A; Fitzpatrick V; Copeland K; Richards J
    J Occup Environ Med; 2022 Aug; 64(8):635-641. PubMed ID: 35673248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Breakthrough Infection Among Vaccinated Population in the United Arab Emirates.
    Dash NR; Barqawi HJ; Obaideen AA; Al Chame HQ; Samara KA; Qadri R; Eldesouki S
    J Epidemiol Glob Health; 2023 Mar; 13(1):67-90. PubMed ID: 36795274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalisation among vaccine breakthrough COVID-19 infections.
    Juthani PV; Gupta A; Borges KA; Price CC; Lee AI; Won CH; Chun HJ
    Lancet Infect Dis; 2021 Nov; 21(11):1485-1486. PubMed ID: 34506735
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.
    Yi S; Choe YJ; Kim J; Kim YY; Kim RK; Jang EJ; Lim DS; Byeon HR; Lee S; Park E; Kim SJ; Park YJ
    Emerg Infect Dis; 2022 Mar; 28(3):753-756. PubMed ID: 35202529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
    Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
    Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization of COVID-19 breakthrough infections, Philippines.
    Velasco JM; Vila V; Diones PC; Valderama MT; Mendez C; Turao-Agoncillo MMM; Chinnawirotpisan P; Manasatienkij W; Joonlasak K; Klungthong C; Jones A; Fernandez S; Navarro FC
    J Clin Virol; 2022 Jun; 150-151():105157. PubMed ID: 35413587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2).
    Klineova S; Farber RS; DeAngelis T; Leung T; Smith T; Blanck R; Zhovtis-Ryerson L; Harel A
    Mult Scler; 2023 Jul; 29(8):990-1000. PubMed ID: 37431628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for severe Covid-19 breakthrough infections: an observational longitudinal study.
    Ben Fredj S; Ghammem R; Zammit N; Maatouk A; Haddad N; Haddad N; Kachroudi M; Rebai S; Laadhari H; Ghodhbani MM; Maatoug J; Ghannem H
    BMC Infect Dis; 2022 Nov; 22(1):894. PubMed ID: 36443699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Talk to Patients About: Breakthrough Infections.
    Price S
    Tex Med; 2021 Oct; 117(10):46. PubMed ID: 34855968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic, immunological, and clinical analysis of COVID-19 vaccine breakthrough infections in Beijing, China.
    Tian D; Song Y; Zhang M; Pan Y; Ge Z; Zhang Y; Ren X; Wen J; Xu Y; Guo H; Yang P; Chen Z; Xu W
    J Med Virol; 2022 May; 94(5):2237-2249. PubMed ID: 35112366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.
    Nelli F; Fabbri A; Virtuoso A; Giannarelli D; Giron Berrios JR; Marrucci E; Fiore C; Schirripa M; Signorelli C; Chilelli MG; Primi F; Pessina G; Natoni F; Silvestri MA; Ruggeri EM
    Curr Oncol; 2023 May; 30(5):5103-5115. PubMed ID: 37232844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.